• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.65% Nasdaq Up 0.55%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    9.85 Down 0.13(1.30%) 11:45AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:9.98
    Open:10.05
    Bid:9.78 x 2900
    Ask:9.80 x 400
    1y Target Est:21.60
    Beta:6.65
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:9.74 - 10.12
    52wk Range:8.84 - 18.48
    Volume:1,038,960
    Avg Vol (3m):1,685,330
    Market Cap:1.02B
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXDown 1.30%1.02B
    BAXUp 1.33%20.92B
    SHPGUp 1.06%47.92B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):516.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.90
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.10

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback